Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PASIREOTIDE vs PATISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PASIREOTIDE vs PATISIRAN: Safety Overview

Metric PASIREOTIDE PATISIRAN
Total FAERS Reports 1,908 2,708
Deaths Reported 117 384
Death Rate 6.1% 14.2%
Hospitalizations 621 1,050
Average Patient Age 51.3 yrs 65.6 yrs
% Female Patients 67.9% 34.2%
FDA Approval Date Dec 15, 2014 Aug 10, 2018
Manufacturer Recordati Rare Diseases, Inc. Alnylam Pharmaceuticals, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription